Evidence map›Paper›PMID 42074677›Full record

ReviewJournal of clinical medicine2026

The Spectrum of Cutaneous Manifestations in Dermatomyositis: A Comprehensive Review.

Magdalena Kutwin, Paulina Karp, Marcelina Kądziela, Alicja Siennicka, Agnieszka Żebrowska

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Magdalena KutwinDepartment of Dermatology and Venereology, Medical University of Lodz, Haller sq. 1, 90-647 Lodz, Poland.
Paulina KarpDepartment of Dermatology and Venereology, Medical University of Lodz, Haller sq. 1, 90-647 Lodz, Poland.
Marcelina KądzielaDepartment of Dermatology and Venereology, Medical University of Lodz, Haller sq. 1, 90-647 Lodz, Poland.
Alicja SiennickaDepartment of Dermatology and Venereology, Medical University of Lodz, Haller sq. 1, 90-647 Lodz, Poland.
Agnieszka ŻebrowskaDepartment of Dermatology and Venereology, Medical University of Lodz, Haller sq. 1, 90-647 Lodz, Poland.ORCID 0000-0002-4548-3080

Funding

Medical University of Lodz [503/1-152-01/503-11-001]
6 · The paper itself

Abstract

Dermatomyositis (DM) is a rare, autoimmune inflammatory myopathy characterized by a heterogeneous clinical course and complex etiopathogenesis. Although classically defined by the coexistence of muscle inflammation and distinctive skin lesions, DM frequently presents as a systemic disease, and, in some patients, cutaneous manifestations may precede muscle involvement or represent the sole clinical feature. The spectrum of skin lesions in DM is broad and includes pathognomonic, characteristic, rare, or atypical manifestations, ranging from classic Gottron's sign and heliotrope rash to uncommon subtypes such as vesiculobullous dermatomyositis, Wong-type dermatomyositis, or flagellate dermatitis. Particular cutaneous phenotypes often correlate with distinct clinical subtypes, autoantibody profiles, systemic involvement, and prognosis. The diversity of dermatological presentations and their resemblance to other dermatoses may delay accurate diagnosis, especially in amyopathic and hypomyopathic forms of the disease. The aim of this review is to comprehensively discuss the wide spectrum of cutaneous manifestations of dermatomyositis, emphasize less recognized and rare dermatological clinical presentations, and highlight their diagnostic and prognostic significance. However, histopathological examination may support the diagnostic process in challenging cases. Early identification of characteristic skin lesions remains crucial for prompt diagnosis, appropriate screening for systemic complications and malignancy, and optimal management. Close interdisciplinary cooperation among dermatologists, rheumatologists, and other specialists is essential to ensure accurate diagnosis and improve outcomes in patients with dermatomyositis.

Indexed as

amyopathic dermatomyositisdermatomyositisdrug-induced dermatomyositishypomyopatic dermatomyositisidiopathic inflammatory myopathiesjuvenile dermatomyositis

Identifiers

PMID42074677
PMCPMC13116588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.